The European Medicines Agency (EMA) has updated their "procedural advice" guidance documents for user of the centralized procedure in the "pre-submission" and "post-authorisation" phase.
Changes included in the updated "pre-submission procedural advice" EMA/339324/2007, May 2011
For More Information Please click : Exalon-EMA Procedural Advice
No comments:
Post a Comment